149 related articles for article (PubMed ID: 11067401)
1. The use of antiplatelet agents in cardiac disease.
Tepper D; Ip RJ; Ip JH
Manag Care Interface; 2000 May; 13(5):76-8. PubMed ID: 11067401
[TBL] [Abstract][Full Text] [Related]
2. Platelet inhibitor therapy for patients with cardiovascular disease: looking toward the future.
Aljaroudi WA; Halabi AR; Harrington RA
Curr Hematol Rep; 2005 Sep; 4(5):397-404. PubMed ID: 16131442
[TBL] [Abstract][Full Text] [Related]
3. The antiplatelet effects of nitrates: is it of clinical significance in patients with cardiovascular disease?
Zhou RH; Frishman WH
Cardiol Rev; 2010; 18(4):198-203. PubMed ID: 20539103
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet agents: current drugs and future trends.
Messmore HL; Jeske WP; Wehrmacher W; Coyne E; Mobarhan S; Cho L; Leya FS; Moran JF
Hematol Oncol Clin North Am; 2005 Feb; 19(1):87-117, vi. PubMed ID: 15639110
[TBL] [Abstract][Full Text] [Related]
5. The P2Y12 receptor as a therapeutic target in cardiovascular disease.
Storey RF
Platelets; 2001 Jun; 12(4):197-209. PubMed ID: 11454254
[TBL] [Abstract][Full Text] [Related]
6. Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease.
Wang TY; Angiolillo DJ; Cushman M; Sabatine MS; Bray PF; Smyth SS; Dauerman HL; French PA; Becker RC
J Am Coll Cardiol; 2012 Mar; 59(10):891-900. PubMed ID: 22381424
[TBL] [Abstract][Full Text] [Related]
7. Current concepts in antiplatelet therapy for cardiovascular disease.
Martinez A
JAAPA; 2004 Mar; 17(3):16-20, 23-4; quiz 51-2. PubMed ID: 15314880
[No Abstract] [Full Text] [Related]
8. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes.
Harrington RA
Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet drugs in cardiovascular diseases.
Weston C; Rao U
Int J Clin Pract; 2003 Dec; 57(10):898-905. PubMed ID: 14712893
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based prescribing and adherence to antiplatelet therapy--how much difference do they make to patients with atherothrombosis?
Husted S
Int J Cardiol; 2009 May; 134(2):150-9. PubMed ID: 19282042
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet medications: old and emerging therapies.
Stone WM; Naidu SG; Chapital A; Money SR
Ann Vasc Surg; 2010 Jan; 24(1):140-8. PubMed ID: 19619976
[TBL] [Abstract][Full Text] [Related]
12. Thienopyridines in cardiovascular disease: focus on clopidogrel resistance.
Siller-Matula J; Schrör K; Wojta J; Huber K
Thromb Haemost; 2007 Mar; 97(3):385-93. PubMed ID: 17334505
[TBL] [Abstract][Full Text] [Related]
13. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
14. Monitoring oral antiplatelet therapy: is it justified?
Ang L; Mahmud E
Ther Adv Cardiovasc Dis; 2008 Dec; 2(6):485-96. PubMed ID: 19124443
[TBL] [Abstract][Full Text] [Related]
15. New players in the field of antiplatelet and anticoagulant therapy in coronary heart disease - current therapeutic issues and hot topics.
Schindler C
Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):413-21. PubMed ID: 19917636
[No Abstract] [Full Text] [Related]
16. Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices.
Faxon DP
Rev Cardiovasc Med; 2005; 6 Suppl 4():S3-14. PubMed ID: 17710074
[TBL] [Abstract][Full Text] [Related]
17. Novel antithrombotic strategies in cardiovascular diseases.
Golino P; Loffredo F; Riegler L; Renzullo E; Cocchia R
Curr Opin Investig Drugs; 2005 Mar; 6(3):298-306. PubMed ID: 15816507
[TBL] [Abstract][Full Text] [Related]
18. Impact of platelet testing on presurgical screening and implications for cardiac and noncardiac surgical procedures.
Bracey AW; Grigore AM; Nussmeier NA
Am J Cardiol; 2006 Nov; 98(10A):25N-32N. PubMed ID: 17097415
[TBL] [Abstract][Full Text] [Related]
19. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
Bryniarski L; Pelc-Nowicka A; Zabojszcz M; Mirek-Bryniarska E
Cardiol J; 2009; 16(2):179-89. PubMed ID: 19387970
[TBL] [Abstract][Full Text] [Related]
20. Protease-activated receptors in cardiovascular health and diseases.
Shah R
Am Heart J; 2009 Feb; 157(2):253-62. PubMed ID: 19185631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
